Stéphane Bancel has been CEO of Moderna since 2011, but it’s almost as if he's led three different companies in the past five years.
First came the pandemic sprint: A biotech with no commercial products became a household name, manufacturing a billion vaccine doses in 2021 and generating roughly $18 billion in annual sales. Then, the descent. As demand for COVID shots ...